1. Walton, C, King, R, Rechtman, L, et al. Rising prevalence of multiple sclerosis worldwide: insights from the atlas of MS, third edition. Mult Scler J 2020; 26: 1816–1821.
Google Scholar | SAGE Journals | ISI2. Laurson-Doube, J, Rijke, N, Helme, A, et al. Ethical use of off-label disease-modifying therapies for multiple sclerosis. Mult Scler J 2021 Aug; 27(9): 1403–1410. doi:10.1177/13524585211030207
Google Scholar | SAGE Journals | ISI3. Schunemann, HJ, Wiercioch, W, Etxeandia, I, et al. Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. Can Med Assoc J 2014; 186: E123–E142.
Google Scholar | Crossref | Medline | ISI4. Piggott, T, Baldeh, T, Akl, EA, et al. Supporting effective participation in health guideline development groups: the guideline participant tool. J Clin Epidemiol 2021; 130: 42–48.
Google Scholar | Crossref | Medline5. GRADEpro [Internet] . [cited 20 April 2021]. Available from: https://gradepro.org/
Google Scholar6. International Guideline Credentialing & Certification Program [Internet] . [cited 4 March 2021]. Available from: https://inguide.org/
Google Scholar7. Guideline Participant Tool (GPT) [Internet] . [cited 4 March 2021]. Available from: https://heigrade.mcmaster.ca/guideline-development/guideline-participants
Google Scholar8. Schünemann, HJ, Al-Ansary, LA, Forland, F, et al. Guidelines international network: principles for disclosure of interests and management of conflicts in guidelines. Ann Intern Med 2015; 163: 548–553.
Google Scholar | Crossref | Medline9. Guyatt, GH, Oxman, AD, Kunz, R, et al. GRADE Guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 2011; 64: 395–400.
Google Scholar | Crossref | Medline10. GRADE handbook [Internet] . [cited 2021 Mar 4]. Available from: https://gdt.gradepro.org/app/handbook/handbook.html
Google Scholar11. Baldeh, T, Saz-Parkinson, Z, Muti, P, et al. Development and use of health outcome descriptors: a guideline development case study. Health Qual Life Outcomes 2020; 18: 167.
Google Scholar | Crossref | Medline12. Higgins, JP, Thomas, J, Chandler, J, et al. Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021) [Internet]. [cited 4 March 2021]. Available from: https://training.cochrane.org/handbook/current
Google Scholar13. Alonso-Coello, P, Schünemann, HJ, Moberg, J, et al. GRADE Evidence to decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: introduction. BMJ 2016 Jun; 28(353): i2016. doi:10.1136/bmj.i2016
Google Scholar | Crossref14. Alonso-Coello, P, Oxman, AD, Moberg, J, et al. GRADE Evidence to decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: clinical practice guidelines. BMJ 2016 Jun; 30(353): i2089. doi:10.1136/bmj.i2089
Google Scholar | Crossref15. Neumann, I, Brignardello-Petersen, R, Wiercioch, W, et al. The GRADE evidence-to-decision framework: a report of its testing and application in 15 international guideline panels. Implement Sci 2015; 11: 93.
Google Scholar | Crossref | Medline16. Moberg, J, Oxman, AD, Rosenbaum, S, et al. The GRADE evidence to decision (EtD) framework for health system and public health decisions. Health Res Policy Syst 2018; 16: 45.
Google Scholar | Crossref | Medline17. Parmelli, E, Amato, L, Oxman, AD, et al. GRADE EVIDENCE TO DECISION (EtD) FRAMEWORK FOR COVERAGE DECISIONS. Int J Technol Assess Health Care 2017; 33: 176–182.
Google Scholar | Crossref | Medline18. Schünemann, HJ, Mustafa, R, Brozek, J, et al. GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health. J Clin Epidemiol 2016; 76: 89–98.
Google Scholar | Crossref | Medline19. Wiercioch, W, Nieuwlaat, R, Akl, EA, et al. Methodology for the American society of hematology VTE guidelines: current best practice, innovations, and experiences. Blood Adv 2020; 4: 2351–2365.
Google Scholar | Crossref | Medline